Viewing Study NCT05619692

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2026-02-22 @ 5:24 PM
Study NCT ID: NCT05619692
Status: COMPLETED
Last Update Posted: 2025-09-15
First Post: 2022-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
Sponsor: Supernus Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mild Cognitive Impairment View
None Mild Dementia View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SAGE-718 View
None Cognitive dysfunction View
None N-methyl-D-aspartate (NMDA) View